Docetaxel Injection

VIV DOC (Docetaxel) is a clinically well-established anti-mitotic chemotherapy medication that works by interfering with cell division. VIVDOC (Docetaxel) is approved by the FDA for treatment of locally advanced or metastatic breast cancer, head and neck cancer, gastric cancer, hormone-refractory prostate cancer and non small-cell lung cancer, VIV DOC (Docetaxel) can be used as a single agent or in combination with other chemotherapeutic drugs as indicated depending on specific cancer type and stage. be The optimal dose scheduling of taxanes remains unconfirmed, but most studies find significant mortality benefit following either a three-week or a one-week administration schedule. The official docetaxel package insert recommends administration every three weeks.